Stockreport

Champions Oncology Reports Quarterly Revenue of $14.1 Million Adjusted EBITDA of $2.0 Million [Yahoo! Finance]

Champions Oncology, Inc.  (CSBR) 
NASDAQ:AMEX Investor Relations: championsoncology.com/investors
PDF provider that offers end-to-end oncology solutions, today announced its financial results for its first quarter of fiscal 2025, ended July 31, 2024. First Quarter High [Read more]